Literature DB >> 22903443

Advising on Preferred Reporting Items for patient-reported outcome instrument development: the PRIPROID.

Zheng-Kun Hou1, Feng-Bin Liu, Ji-Qian Fang, Xiao-Ying Li, Li-Juan Li, Chu-Hua Lin.   

Abstract

OBJECTIVE: The reporting of patient-reported outcomes (PRO) instrument development is vital for both researchers and clinicians to determine its validity, thus, we propose the Preferred Reporting Items for PRO Instrument Development (PRIPROID) to improve the quality of reports.
METHODS: Abiding by the guidance published by the Enhancing the QUAlity and Transparency Of health Research (EQUATOR) Network, we had performed 6 steps for items development: identified the need for a guideline, performed a literature review, obtained funding for the guideline initiative, identified participants, conducted a Delphi exercise and generated a list of PRIPROID items for consideration at the face-to-face meeting.
RESULTS: Twenty three items subheadings under 7 topics were included: title and structured abstract, rationale, objectives, intention, eligibility criteria, conceptual framework, items generation, response options, scoring, times, administrative modes, burden assessment, properties assessment, statistical methods, participants, main results, and additional analysis, summary of evidence, limitations, clinical attentions, and conclusions, item pools or final form, and funding.
CONCLUSIONS: The PRIPROID contains many elements of the PRO research, and this assists researchers to report their results more accurately and to a certain degree use this instrument to evaluate the quality of the research methods.

Entities:  

Mesh:

Year:  2012        PMID: 22903443     DOI: 10.1007/s11655-012-1104-0

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  23 in total

Review 1.  Assessing health status and quality-of-life instruments: attributes and review criteria.

Authors:  Neil Aaronson; Jordi Alonso; Audrey Burnam; Kathleen N Lohr; Donald L Patrick; Edward Perrin; Ruth E Stein
Journal:  Qual Life Res       Date:  2002-05       Impact factor: 4.147

Review 2.  Patient-reported outcomes: assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency.

Authors:  Andrew Bottomley; Dave Jones; Lily Claassens
Journal:  Eur J Cancer       Date:  2008-11-14       Impact factor: 9.162

3.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  Int J Surg       Date:  2010-02-18       Impact factor: 6.071

Review 4.  Guidelines for reporting results of quality of life assessments in clinical trials.

Authors:  M Staquet; R Berzon; D Osoba; D Machin
Journal:  Qual Life Res       Date:  1996-10       Impact factor: 4.147

Review 5.  Patient-reported outcomes in support of oncology product labeling claims: regulatory context and challenges.

Authors:  Yanni Hao
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2010-08       Impact factor: 2.217

Review 6.  Current status of patient-reported outcomes in industry-sponsored oncology clinical trials and product labels.

Authors:  Kathleen Gondek; Pierre-Philippe Sagnier; Kim Gilchrist; J Michael Woolley
Journal:  J Clin Oncol       Date:  2007-11-10       Impact factor: 44.544

7.  Responsiveness of the Chinese Quality of Life Instrument in patients with congestive heart failure.

Authors:  Li Zhao; Kwok-fai Leung; Feng-bin Liu; Jie Chen; Kelvin Chan
Journal:  Chin J Integr Med       Date:  2008-10-14       Impact factor: 1.978

Review 8.  Recommendations on health-related quality of life research to support labeling and promotional claims in the United States.

Authors:  D A Revicki; D Osoba; D Fairclough; I Barofsky; R Berzon; N K Leidy; M Rothman
Journal:  Qual Life Res       Date:  2000       Impact factor: 3.440

9.  The FDA guidance for industry on PROs: the point of view of a pharmaceutical company.

Authors:  Fabio Arpinelli; Francesco Bamfi
Journal:  Health Qual Life Outcomes       Date:  2006-10-31       Impact factor: 3.186

10.  Guidelines for reporting health research: the EQUATOR network's survey of guideline authors.

Authors:  Iveta Simera; Douglas G Altman; David Moher; Kenneth F Schulz; John Hoey
Journal:  PLoS Med       Date:  2008-06-24       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.